NCT06955156 2025-05-02Trilaciclib Combined With Anti-PD-1 Antibody and Chemotherapy in the Treatment of Locally Advanced TNBCCancer Institute and Hospital, Chinese Academy of Medical SciencesPhase 2 Recruiting50 enrolled